Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2003 Dec;79(938):691–694.

Pneumonia due to antibiotic resistant Streptococcus pneumoniae and Pseudomonas aeruginosa in the HAART era

S Allen 1, P Brennan-Benson 1, M Nelson 1, D Asboe 1, M Bower 1, B Azadian 1, B Gazzard 1, J Stebbing 1
PMCID: PMC1742889  PMID: 14707245

Abstract

Antibiotic resistance profiles are useful in directing therapeutic strategies during bacterial infections. Patterns of antimicrobial resistance in Streptococcus pneumoniae and Pseudomonas aeruginosa associated pneumonia were investigated in an HIV-1 infected cohort during the era of highly active antiretroviral therapy. The median CD4 count at presentation was significantly lower for cases of P aeruginosa than for S pneumoniae. However, the number of antibiotic resistant cases of P aeruginosa decreased throughout the study period, while the incidence of S pneumoniae remained unchanged. In contrast to pneumococcal pneumonia, we show that antiretrovirals have protected from pneumonia due to antibiotic resistant P aeruginosa. These findings have implications for the treatment of individuals presenting with serious infections in which antibiotic therapy needs to be instituted before identification and sensitivities are known.

Full Text

The Full Text of this article is available as a PDF (258.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carmeli Y., Troillet N., Karchmer A. W., Samore M. H. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med. 1999 May 24;159(10):1127–1132. doi: 10.1001/archinte.159.10.1127. [DOI] [PubMed] [Google Scholar]
  2. Dworkin M. S., Ward J. W., Hanson D. L., Jones J. L., Kaplan J. E., Adult and Adolescent Spectrum of HIV Disease Project Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis. 2001 Feb 28;32(5):794–800. doi: 10.1086/319218. [DOI] [PubMed] [Google Scholar]
  3. File Jr Thomas M. Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the significance of beta-lactam-resistant Streptococcus pneumoniae. Clin Infect Dis. 2002 Mar 1;34 (Suppl 1):S17–S26. doi: 10.1086/324526. [DOI] [PubMed] [Google Scholar]
  4. Jain A., Jain S., Gant V. Should patients positive for HIV infection receive pneumococcal vaccine? BMJ. 1995 Apr 22;310(6986):1060–1062. doi: 10.1136/bmj.310.6986.1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Janoff E. N., Breiman R. F., Daley C. L., Hopewell P. C. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med. 1992 Aug 15;117(4):314–324. doi: 10.7326/0003-4819-117-4-314. [DOI] [PubMed] [Google Scholar]
  6. Jefferson Tom, Demicheli Vittorio. Polysaccharide pneumococcal vaccines. BMJ. 2002 Aug 10;325(7359):292–293. doi: 10.1136/bmj.325.7359.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jordens J. Z., Paul J., Bates J., Beaumont C., Kimari J., Gilks C. Characterization of Streptococcus pneumoniae from human immunodeficiency virus--seropositive patients with acute and recurrent pneumonia. J Infect Dis. 1995 Oct;172(4):983–987. doi: 10.1093/infdis/172.4.983. [DOI] [PubMed] [Google Scholar]
  8. Manfredi R., Nanetti A., Ferri M., Chiodo F. Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey. Eur J Epidemiol. 2000 Feb;16(2):111–118. doi: 10.1023/a:1007626410724. [DOI] [PubMed] [Google Scholar]
  9. McEllistrem M. Catherine, Mendelsohn Aaron B., Pass Margaret A., Elliott John A., Whitney Cynthia G., Kolano John A., Harrison Lee H. Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. J Infect Dis. 2002 Apr 5;185(9):1364–1368. doi: 10.1086/339882. [DOI] [PubMed] [Google Scholar]
  10. Paul Simon, Gilbert Holly M., Lande Leah, Vaamonde Carlos M., Jacobs Jonathan, Malak Sharp, Sepkowitz Kent A. Impact of antiretroviral therapy on decreasing hospitalization rates of HIV-infected patients in 2001. AIDS Res Hum Retroviruses. 2002 May 1;18(7):501–506. doi: 10.1089/088922202317406646. [DOI] [PubMed] [Google Scholar]
  11. Reacher M. H., Shah A., Livermore D. M., Wale M. C., Graham C., Johnson A. P., Heine H., Monnickendam M. A., Barker K. F., James D. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ. 2000 Jan 22;320(7229):213–216. doi: 10.1136/bmj.320.7229.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sorvillo F., Beall G., Turner P. A., Beer V. L., Kovacs A. A., Kerndt P. R. Incidence and determinants of Pseudomonas aeruginosa infection among persons with HIV: association with hospital exposure. Am J Infect Control. 2001 Apr;29(2):79–84. doi: 10.1067/mic.2001.110367. [DOI] [PubMed] [Google Scholar]
  13. Sullivan J. H., Moore R. D., Keruly J. C., Chaisson R. E. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am J Respir Crit Care Med. 2000 Jul;162(1):64–67. doi: 10.1164/ajrccm.162.1.9904101. [DOI] [PubMed] [Google Scholar]
  14. Taylor I. K., Coker R. J., Clarke J., Moss F. M., Nieman R., Evans D. J., Veale D., Shaw R. J., Robinson D. S., Mitchell D. M. Pulmonary complications of HIV disease: 10 year retrospective evaluation of yields from bronchoalveolar lavage, 1983-93. Thorax. 1995 Dec;50(12):1240–1245. doi: 10.1136/thx.50.12.1240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wolff A. J., O'Donnell A. E. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy. Chest. 2001 Dec;120(6):1888–1893. doi: 10.1378/chest.120.6.1888. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES